Page last updated: 2024-09-03

3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole and alaproclate

3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole has been researched along with alaproclate in 1 studies

*alaproclate: specific 5-hydroxytryptamine uptake inhibitors; RN given refers to (DL)-isomer [MeSH]

*alaproclate: specific 5-hydroxytryptamine uptake inhibitors; RN given refers to (DL)-isomer [MeSH]

Compound Research Comparison

Studies
(3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole)
Trials
(3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole)
Recent Studies (post-2010)
(3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole)
Studies
(alaproclate)
Trials
(alaproclate)
Recent Studies (post-2010) (alaproclate)
1033101521

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bolger, MB; Lee, JD; Ransom, RW; Shih, JC1

Other Studies

1 other study(ies) available for 3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole and alaproclate

ArticleYear
Photoinactivation of serotonin uptake by an arylazido derivative of 5-hydroxytryptamine.
    Molecular pharmacology, 1985, Volume: 28, Issue:2

    Topics: Affinity Labels; Alanine; Animals; Azides; Binding, Competitive; Biological Transport; Cerebral Cortex; Fenfluramine; Kinetics; Male; p-Chloroamphetamine; Photochemistry; Rats; Serotonin; Serotonin Antagonists; Spectrum Analysis

1985